Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Age of ≥ 18 years.
* Diagnosis of locally advanced or metastatic sarcoma of any location and origin.
* Ability to understand and operate in a digital environment.
* Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line.
* Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above.

Exclusion Criteria:

* Limited ability or willingness to report side-effects on an online platform.
* Performance status \>3.
* Life expectancy of \<6 months.
* Participation in an interventional clinical trial with investigational drugs or devices.